Host-targeting therapies for hepatitis C virus infection: current developments and future applications
Chronic hepatitis C virus (HCV) infection is a leading cause of chronic liver diseases and hepatocellular carcinoma (HCC) worldwide. In the past few years, anti-HCV therapies have undergone a revolution with the approval of multiple direct-acting antivirals (DAAs), which enable interferon-free treat...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publishing
2018-03-01
|
| Serier: | Therapeutic Advances in Gastroenterology |
| Online adgang: | https://doi.org/10.1177/1756284818759483 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|